A UPLC-Q/TOF-MS-based plasma and hippocampal metabolomics analysis was conducted to investigate the impact of Erjing Pills on Alzheimer's Disease rats
Journal of Pharmaceutical and Biomedical Analysis · 2026
DOI: 10.1016/j.jpba.2025.117147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026. Verfasst von Xu-Dong Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Institute for Drug Control, NMPA Key Laboratory of Quality Evaluation of Traditional Chinese Patent Medicine, Jiangxi Province Engineering Re…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Alzheimer Disease. Die Arbeit nennt 27 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's Disease (AD), the most common form of dementia, places a significant burden on individuals and society. In line with the doctrines of Chinese medical practice, kidney deficiency and insufficient marrow cannot nourish the brain, leading to insufficient blood, cerebral dysfunction, and ultimately dementia. Erjing Pills contain wolfberry and Polygonati Rhizoma, which tonify the kidneys and improve the essence. Although pharmacological studies have demonstrated that Erjing Pills can be used to prevent and treat AD, the detailed action mechanism is yet to be determined. To comprehensively reveal the mechanism of action of Erjing Pills in the prevention and treatment of AD, three pharmacodynamic evaluations, the water maze test, both hematoxylin-eosin and immunohistochemical techniques were utilized to assess the effects of Erjing Pills on AD rats. Furthermore, plasma and hippocampus metabolomics were conducted by various statistical analyses combined with UPLC-Q/TOF-MS were employed for a comprehensive and accurate analysis of the in vivo anti-AD effects of Erjing Pills. Erjing Pills enhanced learning and memory capacity decreased hippocampal Aβ deposition expression, and enhanced hippocampal morphology in AD rats. After Erjing Pills treatment, 38 plasma metabolites and 15 hippocampal metabolites of AD rats were regressed to levels similar to those of controls. Moreover, pathways impacted by Erjing Pills on AD included arachidonic acid metabolism, retinol metabolism, glycerophospholipid metabolism, and caffeine metabolism. Additionally, adrenaline, leukotriene B4, retinol, and paraxanthine clearly distinguished the Erjing Pills group from the AD group. These findings significantly enhance our comprehension of the metabolic pathways implicated in AD and shed light on the therapeutic mechanisms of Erjing Pills in alleviating symptoms in rats with AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Institute for Drug Control, NMPA Key Laboratory of Quality Evaluation of Traditional Chinese Patent Medicine, Jiangxi Province Engineering Research Center of Drug and Medical Device Quality, Nanchang 330029, Peo…
- School of Pharmacy, Jiangxi University of Chinese Medicine, Nanchang 330004, People's Republic of China.
- Department of Pharmacy, Nanchang Medical College, Nanchang 330052, People's Republic of China.
- Department of Pharmacy, The First Affiliated Hospital, Jiangxi Medical College, Nanchang 330006, People's Republic of China. Electronic address: jianke1986@126.com.
Förderung
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X. D., Huang, L. P., Zhu, N., Yang, X. Y., Yan, F. X., Liu, M., Zhang, P., Wu, Q. Y., Zhou, J., & Wu, Y. (2026). A UPLC-Q/TOF-MS-based plasma and hippocampal metabolomics analysis was conducted to investigate the impact of Erjing Pills on Alzheimer's Disease rats. Journal of Pharmaceutical and Biomedical Analysis. https://doi.org/10.1016/j.jpba.2025.117147
Vancouver
Zhu XD, Huang LP, Zhu N, Yang XY, Yan FX, Liu M, et al. A UPLC-Q/TOF-MS-based plasma and hippocampal metabolomics analysis was conducted to investigate the impact of Erjing Pills on Alzheimer's Disease rats. Journal of Pharmaceutical and Biomedical Analysis. 2026. doi:10.1016/j.jpba.2025.117147
BibTeX
@article{Zhu2026,
author = {Zhu, Xu-Dong and Huang, Li-Ping and Zhu, Na and Yang, Xi-Yang and Yan, Fei-Xia and Liu, Min and Zhang, Peng and Wu, Qiu-Yun and Zhou, Jian and Wu, Yi},
title = {A UPLC-Q/TOF-MS-based plasma and hippocampal metabolomics analysis was conducted to investigate the impact of Erjing Pills on Alzheimer's Disease rats},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2026},
doi = {10.1016/j.jpba.2025.117147}
}
EUVIMED